Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

NCT04551911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Coronavirus
SARS-CoV2 Infection

Interventions

DRUG: Rayaldee
DRUG: Placebo

Sponsor

OPKO Health, Inc.